A Phase 1, Open-Label (JYNNEOS), Double-Blind (TPOXX And Placebo), Multicenter, Randomized, Placebo-Controlled, Drug-Vaccine Interaction Study To Evaluate the Impact of TPOXX on JYNNEOS Immunogenicity
Latest Information Update: 21 Jul 2023
At a glance
- Drugs Tecovirimat (Primary) ; Smallpox vaccine
- Indications Smallpox; Vaccinia virus infections
- Focus Pharmacodynamics
- Sponsors SIGA Technologies
- 17 Jul 2023 Status changed from active, no longer recruiting to completed.
- 22 Dec 2022 Planned primary completion date changed from 1 Dec 2022 to 1 May 2023.
- 22 Dec 2022 Status changed from recruiting to active, no longer recruiting.